Showing results (551-560 of 591) with videos related to

Sort By:
Pageof 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patientsXiao-Ying Shang, Hong-Song Chen, Hua-Gang Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2003
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptorAchim A Jungbluth, Elisabeth Stockert, H J Su Huang, et al.
International Journal of Cancer|March 31, 2011
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigenKazuhiro Kakimi, Midori Isobe, Akiko Uenaka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinomaC R Divgi, N H Bander, A M Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
Genome-wide analysis of cancer/testis gene expressionOliver Hofmann, Otavia L Caballero, Brian J Stevenson, et al.
Cancer Immunity|December 2, 2006
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6)Hearn J Cho, Otavia L Caballero, Sacha Gnjatic, et al.
Cancer Immunity|June 6, 2009
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanomaJianda Yuan, Geoffrey Y Ku, Humilidad F Gallardo, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2010
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyondC M Britten, S Janetzki, S H van der Burg, et al.
Cancer Immunity|April 6, 2006
Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2Ran Zhuang, Yong Zhu, Liang Fang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patientsIan D Davis, Qiyuan Chen, Leone Morris, et al.
Pageof 60